Surrozen (SRZN) Non Operating Investment Income (2020 - 2023)

Surrozen (SRZN) recorded quarterly Non Operating Investment Income of -$1000.0 in Q4 2023, up 75.0% quarter-over-quarter from -$4000.0 in Q3 2023, and down 100.55% on a YoY basis from $183000.0 in Q4 2022.

Surrozen (SRZN) Non Operating Investment Income (2020 - 2023) Analysis & Trends

Surrozen's Non Operating Investment Income history runs 4 years deep, the most recent figure standing at -$1000.0 for Q4 2023.

  • In Q4 2023, Non Operating Investment Income fell 100.55% year-over-year to -$1000.0; the TTM figure through Sep 2024 stood at -$1000.0 (down 100.24% YoY), while the FY2023 annual figure was $241000.0, up 297.54% from the prior year.
  • Non Operating Investment Income was -$1000.0 for Q4 2023 at Surrozen, up from -$4000.0 in the prior quarter.
  • In the past five years, Non Operating Investment Income ranged from a high of $191000.0 in Q1 2023 to a low of -$310000.0 in Q1 2022.
  • Historically, Non Operating Investment Income has averaged -$762.82 across 4 years, with a median of -$4000.0 in 2023.
  • The sharpest annual moves came in 2021 and 2022: Non Operating Investment Income slumped 1127.51% in 2021, then surged 425.0% in 2022.
  • A 4-year view of Non Operating Investment Income shows it stood at -$8391.0 in 2020, then plunged by 1127.51% to -$103000.0 in 2021, then soared by 277.67% to $183000.0 in 2022, then slumped by 100.55% to -$1000.0 in 2023.
  • The last three Non Operating Investment Income figures came in at -$1000.0 (Q4 2023), -$4000.0 (Q3 2023), and $55000.0 (Q2 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Op. Investment Inc. (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - 235,807.00
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - 230,000.00
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn -
9 Abivax 94.37 Bn 94.37 Bn - -
10 Surrozen 225,877.86 -106.68 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2023 -1,000.00
Dec 31, 2023 -1,000.00
Sep 30, 2023 -4,000.00
Sep 30, 2023 -4,000.00
Jun 30, 2023 55,000.00
Jun 30, 2023 55,000.00
Mar 31, 2023 191,000.00
Mar 31, 2023 191,000.00
Dec 31, 2022 183,000.00
Dec 31, 2022 183,000.00
Sep 30, 2022 52,000.00
Sep 30, 2022 52,000.00
Jun 30, 2022 -47,000.00
Jun 30, 2022 -47,000.00
Mar 31, 2022 -310,000.00
Mar 31, 2022 -310,000.00
Dec 31, 2021 -103,000.00
Dec 31, 2021 -103,000.00
Sep 30, 2021 -16,000.00
Sep 30, 2021 -16,000.00